Zobrazeno 1 - 10
of 52
pro vyhledávání: '"Stefan, Symeonides"'
Autor:
Antoine Hollebecque, Victor Moreno, Do-Youn Oh, Ignacio Melero, James Spicer, Iben Spanggaard, Fiona C Thistlethwaite, Stefan Symeonides, Maria Lostes Baradji, Dae Lee, Corinne Rusterholz, Olivera Cirovic, Yvonne Zhao, Nicole Kratochwil, Bernhard Reis, Alexandra Epp, Georgios Kazantzidis
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/3816c6e4a66e4d2c99f92626de198a18
Autor:
Hendrik-Tobias Arkenau, Emiliano Calvo, Alain Mita, Young Kwang Chae, Devalingam Mahalingam, Ugur Sahin, Elena Garralda, Oezlem Tuereci, Vladimir Galvao, Stefan Symeonides, Maria Miguel, Hariz Hassan, Annette Baumhauer, Timo Völker, Marie-Cristine Kühnle, Roman Rösemann, Stefan Strobl
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/f934ebca1c46480bbd8a10a2221a40bb
Autor:
Sebastian M.B. Nijman, Farasat Kazmi, In Hwa Um, Ruud G.P.M. van Stiphout, Gareth L. Bond, Mustafa Elshani, Valentina Ferrari, Ruth Plummer, David J. Harrison, Sarah P. Blagden, James Chettle, Mary Kudsy, Michaela Serpi, Stefan Symeonides, Josephine Morris, Hagen Schwenzer, Leticia Campo, Alistair Easton, Erica De Zan
Publikováno v:
Clinical Cancer Research. 27:6500-6513
Purpose: Nucleoside analogues form the backbone of many therapeutic regimens in oncology and require the presence of intracellular enzymes for their activation. A ProTide is comprised of a nucleoside fused to a protective phosphoramidate cap. ProTide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad843422727b7b653fa57850e1f0ab05
https://doi.org/10.1158/1078-0432.ccr-21-1652
https://doi.org/10.1158/1078-0432.ccr-21-1652
Autor:
Claudio Scuoppo, Gerald Falchook, Elisa Fontana, Anja Williams, Nehal Lakhani, Jeff Evans, Fabio Iwamoto, Meredith McKean, Stefan Symeonides, Alistair McLaren, Jason Henry, Gina Capiaux, Robert Michel, Stephen Kaesshaefer, Alice Bexon, Jim Rotolo
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3ab30bf40c2462adf175c689b465d2aa
https://doi.org/10.1136/jitc-2022-sitc2022.1173
https://doi.org/10.1136/jitc-2022-sitc2022.1173
Autor:
David Pinato, Ruth Plummer, Martin Gutierrez, Jeffrey Yachnin, Aglaia Schiza, Martin Hojgaard, Knut Smeland, William Edenfield, Hans Prenen, Lars Ny, Alan Anthoney, Nuria Kotecki, Stefan Symeonides, Louis Viviers, Jeannie Daniel, Jennifer Pulini, Udai Banerji
Publikováno v:
Regular and Young Investigator Award Abstracts.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::588fc81a0353a39435e2c58342cbb09c
https://doi.org/10.1136/jitc-2022-sitc2022.0622
https://doi.org/10.1136/jitc-2022-sitc2022.0622
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Oliver Bechter, Anna Morena D'Alise, Guido Leoni, Gabriella Cotugno, Loredana Siani, Rosa Vitale, Valentino Ruzza, Irene Garzia, Laura Antonucci, Elisa Micarelli, Sven Gogov, Alessia Capone, Juan Martin-Liberal, Emiliano Calvo, Victor Moreno, Stefan Symeonides, Elisa Scarselli
Publikováno v:
Cancer Research. 83:LB196-LB196
Personalized vaccines hold great promise to exert meaningful clinical efficacy, with durable tumor control maintained by a vaccine–induced memory response. NOUS–PEV is a personalized viral prime–boost cancer vaccine that expresses 60 patient–
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8035a5651de6f94231109940c2653cfd
https://doi.org/10.1158/1538-7445.am2023-lb196
https://doi.org/10.1158/1538-7445.am2023-lb196
Autor:
Lindy G. Durrant, Fayaz Masters, Samantha Paston, Robert Miller, David J. Pinato, Rebecca Herbertson, Anne Armstrong, Stefan Symeonides, Christian Ottensmeier
Publikováno v:
Cancer Research. 83:CT256-CT256
Stressful conditions in the tumor microenvironment induce autophagy in cancer cells as a mechanism to promote their survival. High levels of calcium within autophagosomes activates peptidylarginine deaminase enzymes which convert arginine residues wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5a67ec35aab4b0f2d80813da04087258
https://doi.org/10.1158/1538-7445.am2023-ct256
https://doi.org/10.1158/1538-7445.am2023-ct256
Autor:
Mustafa Elshani, Ying Zhang, Boback Kaghazchi, Alison L. Dickson, Sarah P. Blagden, Stefan Symeonides, Ruth Plummer, David J. Harrison
Publikováno v:
Cancer Research. 83:5962-5962
Background: Immune checkpoint inhibitors (ICIs), including PD-(L)1 pathway inhibitors, are now standard of care for a variety of cancers. Characterization of PD-L1 protein has revealed multiple secreted forms; soluble (sPD-L1) and exosomal (ExoPD-L1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b7bd643df0d269187331acca9042fbaf
https://doi.org/10.1158/1538-7445.am2023-5962
https://doi.org/10.1158/1538-7445.am2023-5962
Autor:
Peter Barrett-Lee, S Waters, Eve Macdonald Chisholm, Chris Twelves, Peter Schmid, Michelle Welsh, Tammy Piper, Robert W. Hill, David Cameron, Murray Brunt, John M. S. Bartlett, Stefan Symeonides, Karen McAdam
Publikováno v:
Cancer Research. 80:P3-11
Background: Src, the first proto-oncogene to be described, is a non-receptor tyrosine kinase interacting with multiple oncogenic pathways, including cell proliferation, survival, angiogenesis and osteoclast activity. Src activation occurs in up to 40
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ad3a5926f4bd757c3388f3c07190bb71
https://doi.org/10.1158/1538-7445.sabcs19-p3-11-09
https://doi.org/10.1158/1538-7445.sabcs19-p3-11-09